46 related articles for article (PubMed ID: 19565909)
1. Chemosensitization of tumor cells: inactivation of nuclear factor-kappa B associated with chemosensitivity in melanoma cells after combination treatment with E2F-1 and doxorubicin.
Hao H; Zhou HS; McMasters KM
Methods Mol Biol; 2009; 542():301-13. PubMed ID: 19565909
[TBL] [Abstract][Full Text] [Related]
2. KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment.
Schön M; Wienrich BG; Kneitz S; Sennefelder H; Amschler K; Vöhringer V; Weber O; Stiewe T; Ziegelbauer K; Schön MP
J Natl Cancer Inst; 2008 Jun; 100(12):862-75. PubMed ID: 18544741
[TBL] [Abstract][Full Text] [Related]
3. Alteration of gene expression in melanoma cells following combined treatment with E2F-1 and doxorubicin.
Hao H; Dong YB; Bowling MT; Zhou HS; McMasters KM
Anticancer Res; 2006; 26(3A):1947-56. PubMed ID: 16827129
[TBL] [Abstract][Full Text] [Related]
4. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells.
Marín YE; Wall BA; Wang S; Namkoong J; Martino JJ; Suh J; Lee HJ; Rabson AB; Yang CS; Chen S; Ryu JH
Melanoma Res; 2007 Oct; 17(5):274-83. PubMed ID: 17885582
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-induced activation of NF-κB in melanoma cells is abrogated by inhibition of IKKβ, but not by a novel IKKα inhibitor.
Pletz N; Schön M; Ziegelbauer K; Emmert S; Liu N; Dobbelstein M; Schön MP
Exp Dermatol; 2012 Apr; 21(4):301-4. PubMed ID: 22320445
[TBL] [Abstract][Full Text] [Related]
6. Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells.
Riganti C; Doublier S; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A
Mol Pharmacol; 2008 Aug; 74(2):476-84. PubMed ID: 18463201
[TBL] [Abstract][Full Text] [Related]
7. Parthenolide complements the cell death-inducing activity of doxorubicin in melanoma cells.
Wozniak M; Szulawska-Mroczek A; Hartman ML; Nejc D; Czyz M
Anticancer Res; 2013 Aug; 33(8):3205-12. PubMed ID: 23898080
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells.
Ho WC; Dickson KM; Barker PA
Cancer Res; 2005 May; 65(10):4273-81. PubMed ID: 15899819
[TBL] [Abstract][Full Text] [Related]
10. NF-kappa B-mediated chemoresistance in breast cancer cells.
Weldon CB; Burow ME; Rolfe KW; Clayton JL; Jaffe BM; Beckman BS
Surgery; 2001 Aug; 130(2):143-50. PubMed ID: 11490342
[TBL] [Abstract][Full Text] [Related]
11. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
12. Selective activation of NF-kappaB and E2F by low concentration of arsenite in U937 human monocytic leukemia cells.
Yamamoto M; Hirano S; Vogel CF; Cui X; Matsumura F
J Biochem Mol Toxicol; 2008; 22(2):136-46. PubMed ID: 18418899
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis.
Chovolou Y; Wätjen W; Kampkötter A; Kahl R
Toxicology; 2007 Mar; 232(1-2):89-98. PubMed ID: 17223244
[TBL] [Abstract][Full Text] [Related]
14. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
15. Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma.
Janus SC; Weurtz B; Ondrey FG
Laryngoscope; 2007 Aug; 117(8):1381-8. PubMed ID: 17607147
[TBL] [Abstract][Full Text] [Related]
16. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.
Kunnumakkara AB; Diagaradjane P; Guha S; Deorukhkar A; Shentu S; Aggarwal BB; Krishnan S
Clin Cancer Res; 2008 Apr; 14(7):2128-36. PubMed ID: 18381954
[TBL] [Abstract][Full Text] [Related]
17. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
[TBL] [Abstract][Full Text] [Related]
18. The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.
Buchholz TA; Garg AK; Chakravarti N; Aggarwal BB; Esteva FJ; Kuerer HM; Singletary SE; Hortobagyi GN; Pusztai L; Cristofanilli M; Sahin AA
Clin Cancer Res; 2005 Dec; 11(23):8398-402. PubMed ID: 16322301
[TBL] [Abstract][Full Text] [Related]
19. Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis.
Liu CA; Wang MJ; Chi CW; Wu CW; Chen JY
Oncogene; 2004 Nov; 23(54):8731-42. PubMed ID: 15480428
[TBL] [Abstract][Full Text] [Related]
20. RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells.
Doublier S; Riganti C; Voena C; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A
Mol Cancer Res; 2008 Oct; 6(10):1607-20. PubMed ID: 18922976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
